I would prefer they keep their powder well and truly dry on the other conditions until after the FDA meeting on PMS P3 trial design and possibly until we commence the P3 trial.
If you announce now, they are just more possible indications for P2 trials and so far with 2591, they are not moving the needle. If you wait until the FDA direction, then I think the announcement of further indications carries more weight and those indications can be modelled based on the guidance and the needle can well and truly move when the path is fully illuminated.
Purely a preference thing on my end but I think it makes sense to my from a psychology/sentiment point of view.
Ann: Trading Halt, page-34
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
0.080(0.62%) |
Mkt cap ! $1.664B | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.35 | $12.99 | $5.557M | 423.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1588 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.06 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |